Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
Sign Up to like & getrecommendations! Published in 2022 at "Intestinal Research"
DOI: 10.5217/ir.2022.00057
Abstract: Background/Aims Patients with inflammatory bowel disease (IBD) are diagnosed with ankylosing spondylitis (AS) often. However, the disease course of patients with both IBD and AS is not well understood. This study aims to evaluate the… read more here.
Keywords: small molecule; ibd group; biologics small; molecule therapies ... See more keywords